Agalsidase beta Side Effects
Not all side effects for agalsidase beta may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to agalsidase beta: intravenous powder for solution
In addition to its needed effects, some unwanted effects may be caused by agalsidase beta. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking agalsidase beta:More common
- Blurred vision
- chest pain or discomfort
- cough producing mucus
- difficulty breathing
- difficulty in moving
- faintness or lightheadedness when getting up from a lying or sitting position suddenly
- feeling unusually cold shivering
- hives or welts
- irregular heartbeat
- joint pain
- muscle aching or cramping
- muscle pains or stiffness
- pounding in the ears
- redness of skin
- shortness of breath
- skin rash
- stomach pain
- swelling of ankles, feet, and lower legs
- swollen joints
- tightness in chest
- unusual tiredness or weakness
- Cloudy or bloody urine
- decreased cardiac output
- difficulty in speaking
- double vision
- feeling of constant movement of self or surroundings
- high blood pressure
- inability to move arms, legs, or facial muscles
- inability to speak
- no blood pressure or pulse
- partial loss of hearing
- pounding or rapid pulse
- problems with muscle control or coordination
- sensation of spinning
- shakiness and unsteady walk
- slow speech
- stopping of heart
- swelling of face
- swelling of the lip or ear
- throat tightness
Some of the side effects that can occur with agalsidase beta may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:More Common
- Acid or sour stomach
- body aches or pain
- body produces substance that can bind to drug making it less effective or cause side effects
- burning, crawling, itching, numbness, prickling, "pins and needles" , or tingling feelings
- dryness or soreness of throat
- feeling sad or empty
- fever, not related to infusion
- lack of appetite
- loss of interest or pleasure
- pain or tenderness around eyes and cheekbones
- paleness of skin
- runny nose
- sensation of change in temperature
- skeletal pain
- stuffy nose; swelling of testes
- tender, swollen glands in neck
- trouble concentrating
- trouble sleeping
- trouble in swallowing
- voice changes
For Healthcare Professionals
Applies to agalsidase beta: intravenous powder for injection
In general, infusion-related side effects have been reported the most frequently. These have included tachycardia, hypertension, urticaria, chest pain, fever, and rigors. Temperature changed sensation and pallor have also been reported.
Cardiovascular side effects have included hypertension (greater than 10%), reports of cardiomegaly, hypotension, and edema.
Nervous system side effects including pain related to Fabry disease and headache have been reported in greater than 10% of patients. Cerebrovascular events (i.e., symptomatic stroke or transient ischemic attack) were reported in 9% of patients. Dizziness and paraesthesia have also been reported.
Gastrointestinal side effects have included reports of dyspepsia and nausea.
Musculoskeletal side effects have included reports of arthrosis and skeletal pain.
Psychiatric side effects have included reports of anxiety and depression.
Respiratory side effects have included reports of bronchitis, bronchospasm, laryngitis, pharyngitis, rhinitis, and sinusitis.
Genitourinary side effects reported by men involved in the placebo controlled study have included testicular pain.
Immunologic side effects have included reports of the development of antibodies to agalsidase beta. Most patients involved in clinical studies developed antibodies within the first 3 months of exposure.
The reported rates of IgG seroconversion during the clinical studies were 88% and 89%. There are reports of decrease in titers after 12 months of treatment and one case that became seronegative. Seroconversion did not affect the efficacy end points. The clinical significance of the antibodies to agalsidase beta is not yet known.
Other side effects including chills have been reported in greater than 10% of patients.
More about agalsidase beta
- Other brands: Fabrazyme
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.